[1] World Health Organization. Global tuberculosis report 2024. https://www.who.int/teams/global-programme-on-tuberculosis-and-lung-health/tb-reports/global-tuberculosis-report-2024. [2024-12-10].
[2] Li WX, Wang XD, Bi B, et al. Influence of temperature and humidity on the incidence of pulmonary tuberculosis in Hainan, China, 2004-2018. Biomed Environ Sci, 2024; 37, 1080−5.
[3] Fan YF, Liu DX, Chen YW, et al. Inferring Mycobacterium tuberculosis drug resistance and transmission using whole-genome sequencing in a high TB-burden setting in China. Biomed Environ Sci, 2024; 37, 157−69.
[4] Leung CC, Yew WW, Chan CK, et al. Smoking adversely affects treatment response, outcome and relapse in tuberculosis. Eur Respir J, 2015; 45, 738−45. doi:  10.1183/09031936.00114214
[5] Sun QF, Li SS, Gao MQ, et al. Therapeutic strategies for tuberculosis: progress and lessons learned. Biomed Environ Sci, 2024; 37, 1310−23.
[6] Guo C, Nie LH, Song YH, et al. Efficacy and safety of combined bedaquiline and delamanid use among patients with multidrug-resistant tuberculosis in Beijing, China. Biomed Environ Sci, 2024; 37, 1195−203.
[7] Quan DH, Kwong AJ, Hansbro PM, et al. No smoke without fire: the impact of cigarette smoking on the immune control of tuberculosis. Eur Respir Rev, 2022; 31, 210252. doi:  10.1183/16000617.0252-2021
[8] Gai XY, Cao WL, Rao YF, et al. Risk factors and biomarkers for post-tuberculosis lung damage in a Chinese cohort of male smokers and non-smokers: protocol for a prospective observational study. BMJ Open, 2023; 13, e065990. doi:  10.1136/bmjopen-2022-065990
[9] Gai XY, Allwood B, Sun YC. Post-tuberculosis lung disease and chronic obstructive pulmonary disease. Chin Med J (Engl), 2023; 136, 1923−8. doi:  10.1097/CM9.0000000000002771
[10] Rao YF, Cao WL, Qu JG, et al. More severe lung lesions in smoker patients with active pulmonary tuberculosis were associated with peripheral NK cell subsets. Tuberculosis (Edinb), 2023; 138, 102293. doi:  10.1016/j.tube.2022.102293
[11] Rao YF, Gai XY, Le YQ, et al. Enhanced proinflammatory cytokine production and immunometabolic impairment of NK cells exposed to Mycobacterium tuberculosis and cigarette smoke. Front Cell Infect Microbiol, 2021; 11, 799276.
[12] Sato Y, Silina K, van den Broek M, et al. The roles of tertiary lymphoid structures in chronic diseases. Nat Rev Nephrol, 2023; 19, 525−37.
[13] Zhao RB, Zhang JH, Ma JL, et al. cGAS-activated endothelial cell-T cell cross-talk initiates tertiary lymphoid structure formation. Sci Immunol, 2024; 9, eadk2612. doi:  10.1126/sciimmunol.adk2612
[14] Xiong J, Zhou L, Tian JY, et al. Cigarette smoke-induced lymphoid neogenesis in COPD involves IL-17/RANKL pathway. Front Immunol, 2020; 11, 588522.
[15] John-Schuster G, Hager K, Conlon TM, et al. Cigarette smoke-induced iBALT mediates macrophage activation in a B cell-dependent manner in COPD. Am J Physiol Lung Cell Mol Physiol, 2014; 307, L692−706. doi:  10.1152/ajplung.00092.2014
[16] Global initiative for chronic obstructive lung disease, GOLD 2025. https://goldcopd.org/wp-content/uploads/2024/11/GOLD-2025-Report-v1.0-15Nov2024_WMV.pdf. [2024-11-11].
[17] National Health and Family Planning Commission of the People's Republic of China. WS 288-2017 Diagnosis for pulmonary tuberculosis. Electronic Journal of Emerging Infectious Diseases, 2018; 59-61. (In Chinese)
[18] Song QS, Guo XH, Zhang LL, et al. New approaches in the classification and prognosis of sign clusters on pulmonary CT images in patients with multidrug-resistant tuberculosis. Front Microbiol, 2021; 12, 714617. doi:  10.3389/fmicb.2021.714617
[19] Linge I, Tsareva A, Kondratieva E, et al. Pleiotropic effect of IL-6 produced by B-lymphocytes during early phases of adaptive immune responses against TB infection. Front Immunol, 2022; 13, 750068. doi:  10.3389/fimmu.2022.750068
[20] Ulrichs T, Kosmiadi GA, Trusov V, et al. Human tuberculous granulomas induce peripheral lymphoid follicle-like structures to orchestrate local host defence in the lung. J Pathol, 2004; 204, 217−28. doi:  10.1002/path.1628
[21] Chen Y, Bharrhan S, Xu JY, et al. B cells promote granulomatous inflammation during chronic Mycobacterium tuberculosis infection in mice. PLoS Pathog, 2023; 19, e1011187. doi:  10.1371/journal.ppat.1011187
[22] Slight SR, Rangel-Moreno J, Gopal R, et al. CXCR5⁺ T helper cells mediate protective immunity against tuberculosis. J Clin Invest, 2013; 123, 712−26.
[23] Linge I, Kondratieva E, Apt A. Prolonged B-lymphocyte-mediated immune and inflammatory responses to tuberculosis infection in the lungs of TB-resistant mice. Int J Mol Sci, 2023; 24, 1140. doi:  10.3390/ijms24021140
[24] Linge I, Kondratieva T, Apt A. B-cell follicles in tuberculous lung: active defenders or modest bystanders? Immunology, 2023; 169, 515-8.
[25] Gopal R, Rangel-Moreno J, Slight S, et al. Interleukin-17-dependent CXCL13 mediates mucosal vaccine-induced immunity against tuberculosis. Mucosal Immunol, 2013; 6, 972−84. doi:  10.1038/mi.2012.135
[26] Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med, 2004; 350, 2645−53. doi:  10.1056/NEJMoa032158
[27] Saint-André V, Charbit B, Biton A, et al. Smoking changes adaptive immunity with persistent effects. Nature, 2024; 626, 827−35. doi:  10.1038/s41586-023-06968-8
[28] Mangan PR, Harrington LE, O'Quinn DB, et al. Transforming growth factor-β induces development of the TH17 lineage. Nature, 2006; 441, 231−4. doi:  10.1038/nature04754
[29] Marin ND, Dunlap MD, Kaushal D, et al. Friend or foe: the protective and pathological roles of inducible bronchus-associated lymphoid tissue in pulmonary diseases. J Immunol, 2019; 202, 2519−26. doi:  10.4049/jimmunol.1801135
[30] Zhao LY, Jin S, Wang SY, et al. Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances. Signal Transduct Target Ther, 2024; 9, 225. doi:  10.1038/s41392-024-01947-5
[31] Yang FY, Yang JH, Wu MJ, et al. Tertiary lymphoid structures: new immunotherapy biomarker. Front Immunol, 2024; 15, 1394505. doi:  10.3389/fimmu.2024.1394505